SCHEMBL7615214

SCHEMBL7615214

Cc1ccc(N(C(N)=NCCc2c[nH]c3ccccc23)c2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.53
RAB9A P51151 1/20 0.53
CDK4 P11802 3/20 0.49
CCND1 P24385 3/20 0.49
KMT2A Q03164 4/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.48
SIRT1 Q96EB6 1/20 0.47
SLC6A4 P31645 1/20 0.47
MEN1 O00255 3/20 0.47
MAPT P10636 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CDK2 P24941 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HTR1A P08908 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2799588 0.78 MC5R (0.64) ADORA2ARAB9AKMT2ALMNAKDM4E
SCHEMBL4628984 0.75 MEN1 (0.80) ADORA2ARAB9ACDK4CCND1KMT2A
SCHEMBL7618325 0.74 ALDH1A1 (0.38) RAB9AALDH1A1
SCHEMBL7615208 0.74 SIRT1 (0.62) RAB9ACDK4CCND1KMT2ALMNA
SCHEMBL7621382 0.73 MIF (0.54) KMT2AKDM4EHTTMEN1MAPT
SCHEMBL7619431 0.71 SCN5A (0.39) RAB9AALDH1A1
SCHEMBL5598639 0.70 HTR2A (0.61) KMT2AKDM4EALDH1A1HTTSLC6A4
SCHEMBL5513944 0.70 MAPT (0.57) ADORA2ARAB9AKMT2ALMNAKDM4E
Tryptamine SCHEMBL28985489 0.69 HTR2A (0.81) KMT2AKDM4EALDH1A1HTTSIRT1
SCHEMBL28236251 0.68 SLC6A4 (0.59) CDK4CCND1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202718-A2 SUBSTITUTED GUANIDINES FOR THE TREATMENT OF CANCER AND PAIN Kadmus Pharmaceuticals, Inc. (US) 2002-05-08 EP disclosed
WO-2001007029-A2 SUBSTITUTED GUANIDINES AND THE USE THEREOF KADMUS PHARMACEUTICALS, INC. (US) 2001-02-01 WO disclosed